We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
GA Perspectives: Dry AMD Follow-Up and a Patient With Advanced Glaucoma and History of Retinal Detachment
Roger A. Goldberg, MD, MBA
Neurotrophic Keratitis: Evolving Staging System and Emerging Agents
John A. Hovanesian, MD
Frank W. Bowden III, MD, FACS
Jennifer Loh, MD
Kelly K. Nichols, OD, MPH, PhD
GA Perspectives: Surgeon With Blind Spots
Charles C. Wykoff, MD, PhD, FACS
Yasha S. Modi, MD, MHS
Hiding in Plain Sight: A Multidisciplinary Effort to Improve Identification and Treatment of Thyroid Eye Disease
Andrea Kossler, MD, FACS
Jennifer Murdock, MD
Eve Bloomgarden, MD
GA Perspectives: Patients Experiencing Difficulties With Reading and Driving
Margaret A. Chang, MD, MS
GA Perspectives: An Unhappy Cataract Patient and a Patient Seeking Cataract Clearance
Taking the Patient-Centered Approach to Mycophenolate Risk Mitigation
Cara Dolin, MD
Jennifer Simpson
Diana Girnita, MD ,PhD
MGD-Associated DED: Expert Guidance on Diagnosing and Treating
Alice T. Epitropoulos, MD, FACS
Michael Greenwood, MD
John D. Sheppard, MD, MMSc, FACS
Real-World Outcomes with Durable Treatments for Retinal Diseases
Christina Y. Weng, MD, MBA, FASRS
Durga Borkar, MD, MMCi
Real-World Treatment of Retinal Disease
Jayanth Sridhar, MD
Sabin Dang, MD
Reconsidering the Algorithm: nAMD
Clinical Evidence for Durable Treatment of DME
A Look at the Numbers: Cost of Durable Treatments in Retinal Disease
Clinical Evidence for Durable Treatment of nAMD
A Closer Look at Real-World Strategies for Treatment-Resistant DME
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education